Clinical response to dabrafenib and chemotherapy in clonally-related histiocytosis and acute lymphoblastic leukemia

Haematologica. 2023 Jun 1;108(6):1707-1712. doi: 10.3324/haematol.2022.281926.

¹ Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec.
² Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada; Department of Pediatrics, Université de Montréal and CHU Sainte-Justine Research Center, Montréal, Québec.
³ Department of Pediatrics, Université de Montréal and CHU Sainte-Justine Research Center, Montréal, Québec.
⁴ Department of Laboratory Medicine, CHU Sainte-Justine, Montréal, Québec.
⁵ Department of Pathology, CHU Sainte-Justine, Montréal, Québec.
⁶ Department of Medical Imaging, Nuclear Medicine, CHU Sainte-Justine, Montréal, Québec.
⁷ Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, CHU Sainte-Justine, Montréal, Québec, Canada; Department of Pediatrics, Université de Montréal and CHU Sainte-Justine Research Center, Montréal, Québec. thai.hoa.tran@umontreal.ca.

No abstract available

Publication types